Amneal Pharmaceuticals, Inc. provided earnings guidance for the full year of 2022. For the year, the company expects net revenue to be between $2.15 billion to $2.25 billion.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
6.45 USD | +0.16% | -5.43% | +6.26% |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+6.26% | 1.99B | |
+38.51% | 727B | |
+32.70% | 599B | |
-6.23% | 354B | |
+18.78% | 328B | |
+1.35% | 277B | |
+16.00% | 243B | |
+8.26% | 205B | |
-5.77% | 203B | |
+6.19% | 164B |
- Stock Market
- Equities
- AMRX Stock
- News Amneal Pharmaceuticals, Inc.
- Amneal Pharmaceuticals, Inc. Provides Earnings Guidance for the Full Year of 2022